Fund holdings · portfolios to September 2026
Mutual funds holding Glenmark Pharmaceuticals
214 mutual funds held Glenmark Pharmaceuticals (GLENMARK) in their portfolios to September 2026: 110 active funds and 104 index funds and ETFs.
What active funds did in September
4 increased, 1 opened a new position, 13 reduced and 6 exited.
5 increased19 reduced
The 10 largest holders, by weight in the fund
| Fund | Weight | In September |
|---|---|---|
| Tata Nifty MidSmall Healthcare Index FundIndex fund | 5.40% | Increased |
| Motilal Oswal Nifty MidSmall Healthcare Index FundIndex fund | 5.39% | Increased |
| Bandhan Focused Fund | 5.29% | Unchanged |
| Invesco India Pharma and Healthcare Fund | 4.86% | Unchanged |
| Mirae Asset Healthcare Fund | 4.78% | Unchanged |
| Motilal Oswal Quant Fund | 4.14% | Unchanged |
| ICICI Prudential Nifty Pharma Index FundIndex fund | 3.56% | Increased |
| Nippon India Nifty Pharma ETFETF | 3.56% | Increased |
| Baroda BNP Paribas Arbitrage Fund | 3.21% | Unchanged |
| Capitalmind Multi Asset Allocation Fund | 3.18% | Unchanged |
All 214 funds that hold GLENMARK, and its active holders month by month
Loading…
Funds publish their portfolios once a month, within about ten days of the month end. A count of funds, not a call on the stock: read it beside the stage and the trend on Glenmark Pharmaceuticals’s page.